等待開盤 09-23 09:00:00
+0.002
+1.90%
<p>BioCardia announced positive preliminary clinical consultation with Japan’s PMDA regarding the CardiAMP Heart Failure Trial results. PMDA requested additional details, including clarifications on composite endpoints, statistical power, NTproBNP subgroup rationale, patient target numbers in Japan, and clinical development status in the U.S. BioCardia is preparing responses with formal consultation expected near year-end. CEO Peter Altman expres...
09-22 12:00
杜甫酒业集团(00986)发布公告,自2025年9月12日起,廖文剑博士已获委任为...
09-12 17:44
GT Biopharma announced the initiation of Cohort 3 in its Phase 1 trial for GTB-3650, its second-generation TriKE therapy for treating relapsed or refractory CD33+ hematologic malignancies. Cohorts 1 and 2 were successfully completed with no safety issues, and the first patient in Cohort 3 has completed the first week of treatment. Early results from Cohorts 1 and 2 show promising immune activity, with NK cell activation and expansion observed. Th...
08-11 11:00
交银国际发布研报称,下调信义光能(00986.HK)目标价13.55%,由4.28港元削至3.7港元。目前多晶硅产能收储计划正在商议中,利好公司收回投资成本。在政策推动下光电供给侧迎转机,维持“买入”评级。
08-06 11:40
杜甫酒业集团(00986.HK)发布公告,刘俊先生(为执行董事)已辞任本公司提名委员会(提名委员会)成员,自2025年6月30日起生效。
07-07 22:41
证券之星消息,截至2025年7月4日收盘,杜甫酒业集团(00986.HK)报收于0.09港元,下跌1.11%,成交量159.1万股,成交额13.83万港元。
07-04 17:52
证券之星消息,截至2025年6月30日收盘,杜甫酒业集团(00986.HK)报收于0.09港元,下跌11.32%,成交量760.6万股,成交额70.83万港元。
06-30 17:55